{
    "2021-06-18": [
        [
            {
                "time": "",
                "original_text": "医药生物行业2021年下半年投资策略：短期有扰动 长期发展趋势向好",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "短期扰动",
                        "长期趋势",
                        "向好"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "信达证券：欧普康视（300595.SZ）OK镜市场高速增长，首予“买入”评级",
                "features": {
                    "keywords": [
                        "信达证券",
                        "欧普康视",
                        "OK镜",
                        "高速增长",
                        "买入评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}